Hereditary spherocytosis: a study of splenectomized persons

Area of Science:

• Hematology
• Immunology

Background:

• Hereditary spherocytosis is a genetic hemolytic anemia.
• Splenectomy is a common treatment for hereditary spherocytosis.
• The spleen's role in immune function and hematological parameters is significant.

Purpose of the Study:

• To evaluate the long-term effects of splenectomy in hereditary spherocytosis patients.
• To compare hematological and immunological parameters between splenectomized, affected non-splenectomized, and unaffected individuals.

Main Methods:

• Comparative study of 61 splenectomized patients, 36 affected non-splenectomized patients, and 77 unaffected family members.
• Analysis of serum immunoglobulin levels (IgM, IgD).
• Assessment of hematological parameters including platelet count, leukocyte count, reticulocyte levels, and presence of Heinz bodies.

Main Results:

• Splenectomized group showed a 25% reduction in serum IgM and a near doubling of IgD levels.
• No fatal bacterial infections were reported over 800 person-years post-splenectomy.
• Elevated platelet, leukocyte, lymphocyte, and monocyte counts persisted long-term after splenectomy.
• Slightly elevated reticulocyte and bilirubin levels, and higher hemoglobin levels were observed in splenectomized patients.

Conclusions:

• Splenectomy in hereditary spherocytosis leads to significant alterations in immunoglobulin profiles.
• The procedure appears safe regarding fatal bacterial infections in the long term.
• Splenectomy influences various hematological parameters, with some remaining elevated years post-surgery.